CEREBAIN BIOTECH CORP. (CBBT) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 9 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Feb 19, 2018 involved a transaction of 160,000 shares valued at $28.8K.
No significant insider buying has been recorded for CBBT in the recent period.
No significant insider selling has been recorded for CBBT in the recent period.
Based on recent SEC filings, insider sentiment for CBBT is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at CEREBAIN BIOTECH CORP. (CBBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading CBBT stock, having executed 9 transactions in the past 90 days. The most active insider is Eric Clemons (Executive), who has made 5 transactions totaling $1.4B.
Get notified when executives and directors at CBBT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 19, 2018 | D. Tate Wesley | Executive | Award | 160,000 | $0.18 | $28.8K | |
| Feb 19, 2018 | Clemons Eric | Executive | Award | 160,000 | $0.18 | $28.8K | |
| Jan 27, 2016 | D. Tate Wesley | Executive | Award | 150,000 | $0.30 | $45.0K | |
| Jan 27, 2016 | Clemons Eric | Executive | Award | 150,000 | $0.27 | $40.5K | |
| Dec 15, 2015 | D. Tate Wesley | Executive | Award | 150,000 | $0.27 | $40.5K | |
| Sep 11, 2015 | Clemons Eric | Executive | Award | 250,000 | $0.31 | $77.5K | |
| Sep 11, 2015 | D. Tate Wesley | Executive | Award | 250,000 | $0.31 | $77.5K | |
| Apr 1, 2015 | Clemons Eric | Executive | Award | 380,625 | $3806.25 | $1.4B | Large |
| Oct 1, 2014 | Clemons Eric | Executive | Award | 48,435 | $1.50 | $72.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 9 | $1.4B | 100.0% |
Insider activity at CEREBAIN BIOTECH CORP. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.2 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Eric Clemons, has transacted $1.4B during this period.